Literature DB >> 32229278

Telehealth: Helping your patients and practice survive and thrive during the COVID-19 crisis with rapid quality implementation.

Ivy Lee1, Carrie Kovarik2, Trilokraj Tejasvi3, Michelle Pizarro4, Jules B Lipoff5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32229278      PMCID: PMC7270881          DOI: 10.1016/j.jaad.2020.03.052

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
To the Editor: Telehealth is an effective, efficient way to triage and deliver timely, quality medical care. In the setting of this public health emergency, telemedicine can maintain access and continuity of care for patients, support colleagues on the front line, optimize in-person services, and minimize infectious transmission of COVID-19 coronavirus. On March 17, 2020, the Centers for Medicare & Medicaid Services (CMS) issued a 1135 Waiver and expanded telehealth coverage for all Medicare patients during the COVID-19 pandemic. What does this mean for clinical practitioners? In short, telemedicine can be used for the evaluation and management of most patients. CMS's policy changes effectively eliminate the main barriers to telemedicine implementation: lack of reimbursement, licensing restrictions, and Health Insurance Portability and Accountability Act (HIPAA) compliance (Table I ). Given current Centers for Disease Control and Prevention guidelines, in-person care should be limited to only the most urgent patients. This minimizes risk of COVID-19 transmission and ensures that finite clinical resources will be equitably distributed to those that need it most.
Table I

Updates in telehealth policy in the COVID-19 crisis∗,+

Pre-COVID-19 telehealth policyCOVID-19
Physician licensureProviders must be licensed in state of the patientWaived but state regulations apply.
Patient populationEstablished patient of the practice (within 3 years)New or established patients
Patient locationEligible originating sitesRural communities (HRSA)All settings, including patient's home.
Technology1Synchronous (live-interactive)Asynchronous (store & forward)No change.
Privacy and securityHIPAA complianceNot enforced.
Synchronous E-visit (provider to patient)Codes: 99201-99215Only for established patients in eligible originating sites and geographic locations.Place of Service code: POS 02Co-insurance/deductibles applyMay be reimbursed at the same amount as in-person visits, when using an interactive audio and video telecommunications system permitting real-time communication between distant site and patient at home.^Providers have flexibility in reducing/waiving out-of-pocket costs for patients. New or established patientsPlace of Service code: POS 11>Modifier: 95<E/M level selection can be based on MDM or time∗∗
Asynchronous E-visit using patient portal (provider to patient)Codes: 99421-3Place of Service code: POS 02Established patients only.New or established patientsPlace of Service code: POS 11>Modifier: 95<
Interprofessional E-consultations (provider to provider)Synchronous, asynchronous, or telephoneNew or established patientsCodes: 99446-99452Place of Service code: POS 11Place of Service code: POS 11>Modifier: 95<
Virtual check-in (provider to patient)

Synchronous, asynchronous, or telephone

Patient initiated

Established patients only

Brief, 5-10 minutes

Cannot result from/lead to E/M service within previous 7 days or next 24 hours.

Low reimbursement

Codes: G2010 (asynchronous)

G2012 (synchronous)

Place of Service code: POS 02

New or established patientsPlace of Service code: POS 11>Modifier: 95<
Other payers
 MedicaidBy state2Evolving by state
 PrivateBy state2Billing modifier 95 (synchronous)Evolving1

E/M, Evaluation and management; HIPAA, Health Insurance Portability and Accountability Act; HRSA, Health Resources and Services Administration.

Medicare policy unless otherwise stated.

Please see AAD Teledermatology Toolkit for the most up to date codes and resources.†CMS is expanding telehealth on a temporary and emergency basis under the 1135 waiver authority and Coronavirus Preparedness and Response Supplemental Appropriations Act. The Department of Health and Human Services (HHS) is announcing a policy of enforcement discretion for Medicare telehealth services furnished pursuant to the waiver under section 1135(b)(8). Changes also include the Interim Rule issued March 30, 2020. ^Retroactive coverage to March 6, 2020. >Practitioners who bill Medicare telehealth services should report POS code that would have been reported had the service been furnished in person.

Time defined as all of the time associated with E/M on the day of service.

Updates in telehealth policy in the COVID-19 crisis∗,+ Synchronous, asynchronous, or telephone Patient initiated Established patients only Brief, 5-10 minutes Cannot result from/lead to E/M service within previous 7 days or next 24 hours. Low reimbursement Codes: G2010 (asynchronous) G2012 (synchronous) Place of Service code: POS 02 E/M, Evaluation and management; HIPAA, Health Insurance Portability and Accountability Act; HRSA, Health Resources and Services Administration. Medicare policy unless otherwise stated. Please see AAD Teledermatology Toolkit for the most up to date codes and resources.†CMS is expanding telehealth on a temporary and emergency basis under the 1135 waiver authority and Coronavirus Preparedness and Response Supplemental Appropriations Act. The Department of Health and Human Services (HHS) is announcing a policy of enforcement discretion for Medicare telehealth services furnished pursuant to the waiver under section 1135(b)(8). Changes also include the Interim Rule issued March 30, 2020. ^Retroactive coverage to March 6, 2020. >Practitioners who bill Medicare telehealth services should report POS code that would have been reported had the service been furnished in person. COVID-19, Medicare used POS 02 to identify telehealth services; however, due to the change in POS code to increase reimbursement, Medicare requests the use of modifier 95 to describe services furnished by telehealth. Time defined as all of the time associated with E/M on the day of service. In the CMS guidance, many restrictions that have roadblocked telehealth adoption for decades have been removed to promote “good faith use of telehealth” in these unprecedented times. To preserve both patient and society's trust, medical communities must hold our standards for professionalism and quality care high. Adherence to state regulations, thorough clinical intake, clear and consistent video connectivity and images, documentation, patient education and transparency, care coordination, data security, and patient privacy should remain a top priority, even in times of crisis. If a non-HIPAA compliant platform is used initially, conversion to a HIPAA-compliant platform should be encouraged as soon as possible. Telehealth offers a tool to provide accessible quality care and maintain connectivity while practicing social distancing. Thoughtful implementation , , of telehealth now allows for sustainable and scalable practice beyond the current crisis. We recommend the following steps for implementing telemedicine into outpatient practices: Use existing systems and platforms (patient portals) to encourage patients to initiate telemedicine when available. Identify highest-risk or urgent patients and schedule them for telemedicine visits. Defer all nonessential visits until a later time. Develop an established pathway for contact and evaluation for urgent patients. Make sure patients know there is a clear line of communication to minimize emergency department overuse for noncritical issues. In the last weeks, we have been proud of the quick actions of our colleagues to adapt and change their way of practice. However, there will always be questions as clinicians change the way they practice. Will telemedicine provide the same quality care as in person? How can we foster patient relationships with electronic distance? Unfortunately, we do not have the resources to see most patients in person, nor can we risk exposing otherwise healthy people to COVID-19. With telehealth implementation, we can see patients remotely, whereas we would not have seen them at all. We anticipate that these changes are necessarily difficult, and our system will grow in new ways. Together as physicians, we will inevitably learn new things about allocating resources, improving efficiency, and optimizing our health system by using telehealth to tackle this pandemic.
  35 in total

1.  Impact of the COVID-19 Pandemic on Immunomodulatory and Immunosuppressive Therapies in Dermatology: Patient and Physician Attitudes in Argentina.

Authors:  S Zimman; M J Cura; P C Lun; C M Echeverría; L D Mazzuoccol
Journal:  Actas Dermosifiliogr       Date:  2020-10-17

Review 2.  Medicolegal aspects of teledermatology.

Authors:  J Arimany-Manso; R M Pujol; V García-Patos; U Saigí; C Martin-Fumadó
Journal:  Actas Dermosifiliogr       Date:  2020-11-02

3.  Building Best Practices for Telehealth Record Documentation in the COVID-19 Pandemic.

Authors:  Shannon H Houser; Cathy A Flite; Susan L Foster; Thomas J Hunt; Angela Morey; Miland N Palmer; Jennifer Peterson; Roberta Darnez Pope; Linda Sorensen
Journal:  Perspect Health Inf Manag       Date:  2022-01-01

4.  Patient clinical documentation in telehealth environment: are we collecting appropriate and sufficient information for best practice?

Authors:  Shannon H Houser; Cathy A Flite; Susan L Foster; Thomas J Hunt; Angela Morey; Miland N Palmer; Jennifer Peterson; Roberta Darnez Pope; Linda Sorensen
Journal:  Mhealth       Date:  2022-01-20

5.  Patient and provider experience and outcomes with synchronous teledermatology during the COVID-19 pandemic.

Authors:  Saniya Shaikh; Eric S Armbrecht; Vruta Kansara; Sheetal Sethupathi; Kavita Darji; Sofia B Chaudhry
Journal:  JAAD Int       Date:  2022-06-16

6.  Prospective Implementation of a Consultative Store-and-Forward Teledermatology Model at a Single Urban Academic Health System with Real Cost Data Subanalysis.

Authors:  Neha N Jariwala; Christopher K Snider; Shivan J Mehta; J Kyle Armstrong; Aaron Smith-McLallen; Junko Takeshita; Carrie L Kovarik; Jules B Lipoff
Journal:  Telemed J E Health       Date:  2020-11-04       Impact factor: 5.033

7.  Spoonful of honey or a gallon of vinegar? A conditional COVID-19 vaccination policy for front-line healthcare workers.

Authors:  Owen M Bradfield; Alberto Giubilini
Journal:  J Med Ethics       Date:  2021-05-11       Impact factor: 2.903

8.  French Teledermatologists: Activity and Motivations Prior to the COVID-19 Pandemic.

Authors:  Mathieu Bataille; Emmanuel Mahé; Valérie Dorizy-Vuong; Charbel Skayem; Anne Dompmartin; Marie-Aleth Richard; Jean Friedel; Florence Ottavy; Marie-Sophie Gautier; Priscille Carvalho; Tu Anh Duong
Journal:  Acta Derm Venereol       Date:  2021-05-26       Impact factor: 3.875

9.  Exploring the feasibility of collecting multimodal multiperson assessment data via distance in families affected by fragile X syndrome.

Authors:  Lauren Bullard; Danielle Harvey; Leonard Abbeduto
Journal:  J Telemed Telecare       Date:  2021-04-12       Impact factor: 6.344

10.  The Impact of Telehealth Implementation on Underserved Populations and No-Show Rates by Medical Specialty During the COVID-19 Pandemic.

Authors:  Ellen B Franciosi; Alice J Tan; Bina Kassamali; Nicholas Leonard; Guohai Zhou; Steven Krueger; Mehdi Rashighi; Avery LaChance
Journal:  Telemed J E Health       Date:  2021-04-07       Impact factor: 5.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.